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Abstract
Ca
2+ influx through voltage-gated Ca
2+ channels (VGCCs) plays important roles in neuronal cell development and function.
Rem2 is a member of the RGK (Rad, Rem, Rem2, Gem/Kir) subfamily of small GTPases that confers potent inhibition upon
VGCCs. The physiologic roles of RGK proteins, particularly in the brain, are poorly understood. Rem2 was implicated in
synaptogenesis through an RNAi screen and proposed to regulate Ca
2+ homeostasis in neurons. To test this hypothesis and
uncover physiological roles for Rem2 in the brain, we investigated the molecular mechanisms by which Rem2 knockdown
affected synaptogenesis and Ca
2+ homeostasis in cultured rat hippocampal neurons. Expression of a cocktail of shRNAs
targeting rat Rem2 (rRem2) reduced the frequency of miniature excitatory postsynaptic currents (mEPSCs) measured 10 d
after transfection (14 d in vitro), but did not affect mEPSC amplitude. VGCC current amplitude after rRem2-targeted
knockdown was not different from that in control cells, however, at either 4 or 10 d post transfection. Co-expression of a
human Rem2 that was insensitive to the shRNAs targeting rRem2 was unable to prevent the reduction in mEPSC frequency
after rRem2-targeted knockdown. Over-expression of rRem2 resulted in 50% reduction in VGCC current, but neither the
mEPSC frequency nor amplitude was affected. Taken together, the observed effects upon synaptogenesis after shRNA
treatment are more likely due to mechanisms other than modulation of VGCCs and Ca
2+ homeostasis, and may be
independent of Rem2. In addition, our results reveal a surprising lack of contribution of VGCCs to synaptogenesis during
early development in cultured hippocampal neurons.
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Introduction
Ca
2+ influx through voltage-gated Ca
2+ channels (VGCCs)
controls diverse neuronal functions such as neurotransmitter
release and excitation-transcription coupling. Extensive regulatory
mechanisms, such as phosphorylation of the channels’ pore-
forming a1 subunits by multiple kinases [1] or interaction with
calmodulin [2–4], fine-tune VGCC activity and the resultant Ca
2+
influx to modulate neuronal behavior.
Recently the RGK (Rad, Rem, Rem2, Gem/Kir) subclass of
small GTPases have received considerable attention as VGCC
modulators because of their potent inhibitory properties, but their
mechanism of action and contribution to physiology remains
controversial [5]. Exogenous expression of a RGK in any cell with
high voltage-activated (CaVb-containing) VGCCs results in
inhibition of the Ca
2+ current in a CaVb-dependent manner [6–
9]. In addition to regulating VGCCs, Rad and Gem (but not Rem
nor Rem2) can bind and inhibit Rho kinase b, and thereby affect
cell-shape [10]. The RGK GTPases further stand apart from other
small G proteins because they are regulated by transcription
[11,12] and only weakly, if at all, by guanine nucleotides [13]. This
suggests that Ca
2+ channel activity can be titrated through
transcriptional control of endogenous RGKs [8].
While multiple studies have extensively characterized the
biophysics of RGK-mediated inhibition of VGCCs and the
biochemistry of interaction with Ca
2+ channel subunits, attempts
to delineate physiological roles for RGKs have been limited to three
reports, only one of which focused on the brain. Knockout of Rad
increased susceptibility to cardiac hypertrophy after pressure
overload [14]. Whether this resulted from loss of Ca
2+ channel
inhibition was not explored, but endogenous Rad could foster tonic
inhibition of cardiac CaV1.2 Ca
2+ channels as shown by shRNA
knockdown in isolated myocytes [15]. Rem2, which is expressed in
adult rat brain [16], was identified in an RNAi screen as a regulator
of synaptogenesis [17]. RNAi or shRNA knockdown strategies
targeting Rem2 in cultured neonatal hippocampal neurons
decreased the density of both glutamatergic and GABAergic
synapses. Although altered Ca
2+ homeostasis after Rem2 knock-
down was not assessed in that study, over-expression of Rem2 in
neurons had previously been shown capable of inhibiting VGCCs
[18].Together,theseresultssuggestedaconnectionbetweencalcium
homeostasis, mediated by Rem2, and synapse development [17].
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25741In an attempt to establish the physiological role of Rem2 in
neurons and to address the hypothesis that RGK-mediated control
of Ca
2+ homeostasis regulates synapse development, we set out to
investigate the molecular mechanisms by which Rem2 knockdown
affected synaptogenesis. The reproducibility of synaptogenesis
readouts and the ability to measure VGCC currents in cultured
hippocampal neurons offered an opportunity to explore the roles
of endogenous RGKs and their effects upon VGCCs and Ca
2+
homeostasis in excitable cells.
Materials and Methods
Ethics Statement
Animals were handled according to National Institutes of
Health Guide for the Care and Use of Laboratory Animals and
approved by Duke University Animal Care and Welfare
Committee (approval A315-10-2).
Molecular Biology
The GFP-rRem2 and GFP-hRem2 were constructed by
subcloning rat Rem2 (rRem2) or human Rem2 (hRem2) into
the first multiple cloning site (MCS) in pEGFP-C1 (Clontech, CA).
Rat Rem2 shRNAs cloned into the pSuper shRNA expression
vector (OligoEngine, WA) were kindly provided by M.E. Green-
berg (Harvard) [17].
Neuronal Cultures and Electrophysiology
Hippocampi from 1–2 d newborn rat (Sprague Dawley strain)
were dissociated and plated on glass coverslips in 12-well cell
culture plate in the density of 100,000/ml as described previously
[19]. The cells in the wells were randomly assigned into
experimental groups. Hippocampal neurons 4 d in vitro (DIV)
were transfected with either GFP or GFP-rRem2 for the
experiments assessing Rem2 overexpression; or co-transfected
with GFP and pool of the three shRNA constructs targeting
rRem2 using calcium phosphate precipitation as described [17].
The pSuper plasmid without an insert was used as a control. In the
rescue experiments, GFP-hRem2 and shRNAs were co-transfect-
ed. Electrophysiological recordings were performed at 3, 4, and
10 d after transfection (7, 8, 14 DIV). mEPSCs and VGCC
currents were obtained at room temperature from GFP-positive
cells in the whole-cell voltage patch-clamp configuration with an
Axopatch 200B amplifier. For mEPSC recordings the pipette
internal solution contained the following (in mM): 120 potassium
gluconate, 10 KCl, 5 MgCl2, 0.6 EGTA, 5 HEPES, 0.006 CaCl2,
10 phosphocreatine disodium, 2 Mg-ATP, 0.2 GTP, and 50 U/ml
creatine phosphokinase, pH 7.2; the external solution contained
(in mM): 119 NaCl, 3 KCl, 20 HEPES, 2 CaCl2, 2 MgCl2,3 0
glucose, 0.001 tetrodotoxin, 0.001 glycine and 0.1 pictrotoxin,
pH 7.3. For VGCC current recordings, the pipette solution
contained (in mM): 135 CsMeSO3, 5 CsCl, 5 EGTA, 1 MgCl2,4
Mg-ATP, and 10 HEPES, pH 7.3; recording solution contained
(in mM): 115 NaCl, 3 KCl, 10 HEPES, 5 CaCl2, 2 MgCl2,1 0
glucose, 0.0005 tetrodotoxin, 20 tetraethylammonium chloride,
and 5 4-aminopyridine, pH 7.3. Currents were sampled at 10 kHz
and filtered at 2 kHz. VGCC currents were induced by a ramp
step from 280 mV to +50 mV over 500 ms after a 50 ms step to
280 mV from a holding potential of 270 mV. Series resistance
ranged from 6–20 MV without compensation.
PCR Quantitative Analysis
Total mRNA was purified from neurons cultured for the
indicated times using RNAeasy Plus Mini kit (Qiagen, CA). Real-
time PCR quantification was performed using the BIO-RAD
iCycler system (Bio-Rad Laboratories, CA). At the completion of
PCR (a total of 45 cycles), the relative amount of target message in
each reaction was determined from the detection threshold cycle
number (Ct), which is inversely correlated with the abundance of
the message’s initial level, which was normalized to the Ct for
actin, obtained simultaneously.
GFP Immunoblot
HEK293 cells were washed with ice-cold TBS (150 mM NaCl
and 50 mM Tris, pH 7.5), harvested, and resuspended in ice-cold
TBS with 1% Triton X-100 and protease inhibitor 2 d after the
cells had been transfected with the indicated combination of
plasmids. Cells were lysed by pipetting up and down and then
centrifuged at 17,000 X g for 10 min. Protein was then separated
by SDS-PAGE, transferred to nitrocellulose, and immunoblotted
with anti-GFP antibody (Covance, Princeton, NJ) and detected by
chemiluminescence with SuperSignal West Pico (Pierce) on a
Kodak Image Station 4000R Pro (Carestream Health, NY).
Quantification of protein was performed by measuring intensity of
the bands using KODAK MI software.
Immunocytochemistry
Hippocampal neurons plated on coverslips at 4 DIV were
transfected with either GFP or GFP-rRem2; or co-transfected with
GFP and pool of the three shRNAs targeting rRem2 or GFP and
pSuper plasmid without an insert as a control. The neurons were
fixed with 4% paraformaldehyde in phosphate buffer saline (PBS)
10 d after transfection (14 DIV) and permeabilized with 0.02%
saponin in PBS. After blocking with 10% bovine serum albumin
(BSA) in PBS the fixed neurons were incubated with 1:100 goat
polyclonal antibody against Rem2 (C-13; Santa Cruz Biotechnol-
ogy, CA) in PBS with 5% BSA over night at 4uC. Secondary Cy3-
conjugated bovine anti-goat IgG antibody (Jackson ImmunoR-
esearch Laboratory, PA) was applied at 1:1,000 at room
temperature for 1 h. Coverslips were mounted on slides with
fluoromount-G (SouthernBiotech, AL). Images were obtained on a
Zeiss LSM 510 inverted confocal microscope with a 40x/1.30 oil
objective (Duke Light Microscopy Core Facility) by sequential
scanning excited with 488 nm Argon and 561 nm Diode lasers
and filtered at the range of 505–550 nm for GFP and 575 nm for
Cy3. A 118 mm pinhole was used for both green and red channels.
Focus was adjusted using the GFP signal. Laser intensity and offset
for Cy3 red channel were optimized based on preliminary images
from neurons transfected with GFP-Rem2 (over-expression). A
laser intensity of 5.9% with detector gain 601 and offset -0.472 was
set for red channel for all images acquired. By using this setting we
ensured that Cy3 fluorescent signal for all images obtained from
different neurons was not saturated. Four scans were digitally
averaged. Images were analyzed with ImageJ 1.35p (NIH). The
mean fluorescent intensity within the soma was corrected by
subtracting a background value, which was calculated as the
mean+2SD of 4 random local areas outside of the soma.
Statistics
All data analyses were performed using Microsoft Excel 2007.
Numerical averages are presented as mean 6 SEM. Unless
otherwise stated, statistical significance was calculated using the
unpaired two-sample Student’s t test.
Results
To determine whether the effects upon synaptogenesis by Rem2
knockdown could be mediated by alterations in calcium
homeostasis, we first tested whether rRem2 was capable of
Synaptogenesis in Neurons is Rem2-Independent
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expected from previous reports using sympathetic and dorsal root
ganglion neurons and other cell types [8,18], over-expression of
rRem2 decreased VGCC currents in hippocampal neurons. We
observed more than 50% reduction of VGCC currents 4 d after
transfection (Fig. 1, A and B). Current amplitude was still reduced
6 d after transfection (not shown), but reduction 10 d after
transfection was no longer significant (Fig. 1B). Surprisingly,
neither the miniature excitatory postsynaptic current (mEPSC)
frequency nor amplitude was affected by Rem2 over-expression in
hippocampal neurons (Fig. 1, C, D, and E), despite the marked
reduction in VGCC currents. Thus, the signaling pathways
mediating synaptogenesis are tolerant of a significant reduction
in whole-cell VGCC activity.
Since rRem2 was able to reduce VGCC currents, we tested
whether rRem2 shRNA relieved tonic inhibition of VGCCs by
endogenous Rem2. We measured whole-cell VGCC currents in
cultured rat hippocampal neurons at 4 and 10 d after expression
of a cocktail of shRNAs targeting rRem2. Current amplitude from
neurons with expression of the control plasmid (empty vector) was
not different from non-transfected cells (14.661.0 pA/pF vs.
13.361.6 pA/pF, P=0.51), showing that the transfection
procedure had no effect on the VGCC. Nor, however, was
current amplitude after rRem2-targeted knockdown in neurons
different from that in control neurons transfected with empty
vector at either 4 or 10 d post transfection (Fig. 2A). This was not
because the shRNA was incapable of reducing Rem2 protein (see
data below showing that shRNA was effective at reducing Rem2
protein expressed in HEK cells; an equivalent immunoblot
analysis of Rem2 protein after knockdown in culture hippocampal
neurons was not possible because of the comparatively low
transfection efficiency in neurons, but see immunostaining analysis
below).
A possible explanation for the lack of efficacy of Rem2 shRNA
was that the level of Rem2 mRNA in these cultures was negligible;
thus, even effective targeting of Rem2 would have little effect upon
Rem2 protein levels and thus upon VGCC currents. To
investigate this possibility, we first performed semi-quantitative
PCR to measure the relative amounts of Rem2 mRNA in cultured
hippocampal neurons at 1, 4, 8 and 14 DIV (Fig. 2B). We found
that the amount of Rem2 mRNA decreased by .80% by day 4 in
vitro (when transfection with shRNA was performed for the
physiology experiments) and by 14 DIV was further reduced to
,10% of the level at 1 DIV. Thus, there was comparatively little
Rem2 mRNA to target with shRNA at the critical time period in
which transfection was performed.
So, how does knockdown of Rem2 affect synaptogenesis? To
attempt to address this question, we first confirmed that
Figure 1. Over-expression of Rem2 reduced VGCCs without changes in mEPSCs in cultured hippocampal neurons. A, Exemplar VGCCs
were recorded from neurons transfected with GFP-rRem2 or GFP. The currents were induced by a ramp protocol 280 mV to +50 mV over 500 ms
after a 50 ms step to 280 mV from a holding potential of 270 mV. B, Summarized VGCC currents recorded 4 (N=7) and 10 d (N=8) after Rem2 over-
expression, showing VGCCs decreased markedly at 4 d (p=0.03) and there was not significant difference at 10 d (p=0.1). C, Exemplar recording of
mEPSCs from neurons transfected with GFP-rRem2 or GFP only. D, and E, mEPSCs showed no change in mEPSCs frequency or amplitude at 4 d post-
transfection (N=9–10; frequency p=0.11; amplitude p=0.53) or 10 d post-transfection (N=15; frequency p=0.19; amplitude p=0.36).
doi:10.1371/journal.pone.0025741.g001
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cultured neurons reduced the frequency of spontaneously
occurring mEPSCs, as previously reported [17]. Indeed, the
shRNA cocktail effectively reduced mEPSC frequency measured
10 d after transfection (14 DIV), as shown in Fig. 3A–B. The
reduction in mEPSC frequency took time to manifest; no
difference in frequency was detected 4 d after shRNA transfection
(Fig. 3B). ShRNA did not affect mEPSC amplitude (Fig. 3C).
Expression of the control plasmid (empty vector) had no effect on
mEPSC frequency when compared to non-transfected cells
(148630 event/min vs. 103618 event/min, P=0.22). Since we
did not observe a correlation between shRNA-mediated reduction
in mEPSC frequency and relief of tonic VGCC inhibition (Fig. 2A),
the observed reduction in mEPSC frequency after shRNA
treatment was more likely due to mechanisms other than
modulation of VGCCs and Ca
2+ homeostasis.
Figure 2. Rat Rem2 shRNAs did not change VGCC peak currents in hippocampal neurons. A, VGCC currents from control neurons and
neurons transfected with rRem2-targeted shRNAs. There was no change in current density at either 4 d post-transfection (N=11, p=0.24) or 10 d
post-transfection (N=5–7, p=0.48). B, Rem2 mRNA relative values in hippocampal neuron culture was measured at 1, 4, 8 and 14 DIV (N=5–9) with
PCR quantitative analysis. The relative value was normalized to the value of 1 DIV.
doi:10.1371/journal.pone.0025741.g002
Figure 3. Rat Rem2 shRNAs reduced mEPSCs frequency in hippocampal neurons. A, Exemplar recording of mEPSCs from neurons
transfected with rRem2-targeted shRNAs or the control plasmid. B, and C, Summarized mEPSCs frequency and amplitude 4 (N=6) and 10 d (N=12)
after transfection, showing that the mEPSCs frequency was reduced significantly at 10 d after transfection of shRNAs compared with control
transfection (p=0.006). There was no change in amplitude (p=0.55).
doi:10.1371/journal.pone.0025741.g003
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shRNAs were independent of Rem2. To test for this possibility, we
attempted a rescue experiment in which we expressed a shRNA-
insensitive hRem2 (amino acid sequence is 93% identical) along
with the rRem2-targeted shRNAs. We first confirmed that the
shRNAs were capable of reducing levels of rRem2 protein while
sparing hRem2. In HEK cells expressing a GFP-tagged rRem2,
the rRem2-targeted shRNAs reduced protein 59% (compared to
control); protein levels of a GFP-tagged hRem2 were unaffected
(Fig. 4, A and B). We then confirmed that the GFP-hRem2 was
active in rat hippocampal neurons: when over-expressed, it
reduced whole-cell VGCC currents by 66% (Fig. 4C). Although
GFP-hRem2 was capable of reducing VGCC currents and was
insensitive to the shRNAs targeting rRem2, it was unable to
prevent the reduction in mEPSC frequency by the rRem2-
targeted shRNAs, however. As shown in Fig. 4D, and consistent
with data in Fig. 3 and a previous report [17], the rRem2-targeting
shRNAs reduced the mEPSC frequency in hippocampal neurons
10 d post transfection compared to control (vector only) neurons,
but co-expression of GFP-hRem2 failed to restore the mEPSC
frequency to control cell levels.
This suggested the possibility that shRNA, although reducing
mEPSC frequency, did not affect endogenous Rem2 protein. We
tested this hypothesis by quantifying Rem2 immunostaining in
hippocampal neurons after shRNA treatment with an antibody
that can detect a , 35 kDa protein (the predicted mass of Rem2)
in mouse brain tissue extracts (see manufacturer’s data). First, we
tested whether the antibody was also capable of detecting Rem2 in
cultured hippocampal neurons by comparing immunofluorescence
within GFP-positive neurons transfected with GFP-tagged rRem2,
which we showed was functional as evidenced by its ability to
reduce Ca
2+ current in transfected neurons (see Fig. 1). In the
soma of neurons transfected with GFP-rRem2 we observed
significantly higher immunofluorescence compared to control
neurons transfected with GFP only (Fig. 5A–B). No difference in
the pattern of immunofluorescence was observed in the dendritic
arbor. We then tested whether shRNA diminished endogenous
somatic Rem2 under the same conditions that reduced mEPSC
frequency and observed no difference in the level of immunoflu-
orescence (Fig. 5C–D) when compared to control treated cells.
Together, the inability of the GFP-hRem2 to restore the mEPSC
frequency and the lack of a detectable effect of shRNA on
Figure 4. GFP-hRem2, which was insensitive to rRem2-targeted shRNAs, could not rescue the reduction in mEPSCs frequency
induced by shRNAs. A, and B, immunoblot for GFP of lysates of untransfected HEK cells or cells transfected with GFP, GFP-rRem2 plus either rRem2
shRNAs or empty vector, and GFP-hRem2 plus either rRem2 shRNAs or empty vector. The rRem2-targeted shRNAs reduced GFP-rRem2 expression
(N=4, p=0.03). C, VGCC currents recorded from cultured hippocampal neurons 3 d after transfection with GFP-hRem2 (N=8) or GFP (N=7). GFP-
hRem2 reduced VGCC currents (p=0.03). D, mEPSC frequency recorded at 4 d (N=8) and 10 d (N=16–21) after transfection with empty vector,
rRem2-targeted shRNAs, or rRem2-targeted shRNAs together with GFP-hRem2. Transfection with rRem2-targeted shRNAs reduced mEPSCs frequency
at 10 d compared to control (p=0.02). Co-transfection with GFP-hRem2 did not rescue the effect of rRem2-targeted shRNAs (p=0.12).
doi:10.1371/journal.pone.0025741.g004
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upon mEPSCs are independent of Rem2.
Discussion
The physiologic roles of RGK proteins remain poorly
understood despite recent studies elucidating the molecular
mechanisms by which RGKs inhibit VGCCs [9]. Previous
explorations of RGK roles in physiology have relied almost
exclusively upon over-expression in cell culture systems or in
transgenic animals [20] and have not addressed the roles of
endogenous RGKs. Exceptions are the set of experiments
demonstrating that knockout of Rad increased susceptibility to
cardiac hypertrophy [14] and, separately, that knockdown of Rad
in cardiac myocytes increased L-type VGCCs [15]. At least in
heart, those data together suggest that Rad is capable of tonic
inhibition of VGCCs and that excessive relief of that inhibition (by
Rad knockout) is pathologic. How Rad is regulated under
physiologic conditions in heart, and the consequent effects upon
VGCCs has not been examined, but remains an exciting area for
future study.
In this context, the reported role for Rem2 on synaptogenesis
[17] offered a new insight into RGK physiology and was a major
motivation for this study. Rem2 knockdown in cultured hippo-
campal neurons decreased mEPSC frequency—effect that was
replicated in this study. The lower mEPSC frequency suggests
either a reduction in release probability in the presynaptic neuron
or a decreased number of synaptic contacts on the postsynaptic
neuron in which recordings were performed [21]. Since
transfection efficiency was relatively low (,20 – 30%), it is
unlikely that the observed effects were presynaptic; thus, we
assume that the effects were limited to a decrease in the number of
synapses generated on the postsynaptic neuron in which mEPSCs
were recorded. How Rem2 could affect synapse formation in a
postsynaptic neuron is unclear, but several lines of evidence from
our results suggest that the mechanism does not include regulation
of Ca
2+ homeostasis through inhibition of VGCCs. First,
overexpression of Rem2 and a resultant decrease in VGCC
currents failed to affect either mEPSC frequency or amplitude.
Second, expression of shRNAs targeting Rem2 did not affect
VGCC currents. Rather, our results suggest that the reduction in
mEPSCs after shRNAs targeting Rem2 may be independent of
Figure 5. shRNA did not reduce endogenous Rem2 measured by immunocytochemistry in hippocampal neurons. A and C, Exemplar
images of neurons transfected with GFP or GFP-rRem2; or co-transfected with GFP and control vector versus GFP and a pool of rRem2 shRNAs. Left
column, expressed GFP; right column, rRem2 detected with antibody against Rem2 and visualized with secondary antibody Cy3. Scale bar, 20 mm. B
and D, Summarized GFP and Cy3 fluorescent levels indicated with mean gray value. Neurons overexpressing rRem2 (n=41) showed significantly
stronger fluorescent signal than control neurons (N=15) (p=0.0003). There was not significantly difference between neurons transfected with rRem2
shRNA (N=51) and control plasmid (N=48) (p=0.25).
doi:10.1371/journal.pone.0025741.g005
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presence of a shRNA-insensitive Rem2 and we could not detect
any change in the level of Rem2 after shRNA under same
conditions that produced changes in synaptogenesis. While it is
possible that the hRem2 failed to complement the reduction in
rRem2 in rat hippocampal neurons, the 93% identity between the
2 proteins suggests that this was an unlikely scenario. Moreover,
hRem2 was equally effective as rRem2 in reducing VGCC current
after over-expression, demonstrating that hRem2 was functional in
hippocampal neurons, at least for this well-established measure of
Rem2 efficacy. The failure of the rescue construct in these
experiments is significant since it has been demonstrated shRNAs
can affect synapses through activation of innate antiviral response
pathways—independent of the shRNA target—leading specifically
to loss of dendritic spines and a reduction in mEPSCs [22]. In
contrast to our failed attempts, it was recently shown that the
reduction in synapses after Rem2 shRNA knockdown, as
measured by immunocytochemical techniques, could be rescued
by a shRNA-resistant Rem2 [23]. The reasons for the different
results are not clear, but one possibility may be distinctions in the
way synaptogenesis was quantified. We measured a functional
readout, mEPSCs, while the other report measured parameters
such as dendritic density. As noted above, the failure to rescue in
our experiments cannot be attributed to lack of efficacy of the
hRem2 rescue construct, since we were able to confirm that
hRem2 was functional as a VGCC inhibitor. Thus, the
discrepancy between the rescue results could imply that morpho-
logical changes (measured by Ghiretti and Paradis [23]) and the
functional changes measured in this report are independent.
Another difference between these reports was that we were unable
to detect an effect of shRNA on endogenous Rem2 immunostain-
ing, using the same shRNA constructs and under the same
conditions that produced the functional readout (a reduction in
mEPSCs) by which Rem2 was originally identified as a mediator
of synaptogenesis [17]. This discrepancy may derive from the
different primary antibodies used (in this report, a commercial
antibody demonstrated to detect a protein of the predicted
molecular weight within adult mouse brain lysates; Ghiretti and
Paradis used a custom antibody [23]). Thus, the failure of the
shRNA to affect VGCCs in our experiments, no detectable change
in Rem2 by immunostaining after shRNA, and the lack of any
effect on mEPSCs observed after Rem2 over-expression provides
little support for a Rem2-mediated effect. We considered the
possibility that the Rem2 shRNAs targeted other mRNAs, but
search of available databases did not identify any other targets (not
shown).
Rem2 is expressed in human embryonic stem cells, in which it
maintains the cell cycle and controls proper differentiation towards
ectoderm, suggesting a role in neuronal development [24] but its
expression pattern during neonatal development in the brain is not
known. We tested Rem2 mRNA levels with quantitative RT-PCR
in hippocampal neuron cultures and found that the relative level of
Rem2 mRNA declined by ,80% at 4 DIV compared to 1 DIV,
and that the level remained low level through 14 DIV (the extent
of our experimental time course). The period between 4 DIV and
12 DIV is a critical period for the formation of functional synapses,
as indicated by data that only 11% of neuron pairs have evoked
synaptic transmission at 4 DIV compared to 75% by 12 DIV [25].
While we cannot be certain that the low level of Rem2 mRNA
correlates to a low protein level, those data do suggest that there is
not a significant transcriptional regulation of Rem2 during this
important developmental time.
Another interesting outcome of our experiments is that the 50%
reduction in VGCC activity for up to 6 days in culture (after Rem2
overexpression) did not alter synaptogenesis. That development of
synapses can tolerate a significant and sustained reduction in Ca
2+
influx through VGCCs suggests two possibilities: either that any
role for elevated intracellular Ca
2+ in synaptogenesis is supported
through other Ca
2+ entry sources or that Rem2 overexpression
triggered compensatory increases through other entry sources. In
support of the former hypothesis is extensive evidence that
VGCCs, especially CaV1.2 L-type Ca
2+ channels, have prominent
roles in activity-dependent gene expression, but other Ca
2+ entry
sources appear to play more prominent roles during early
development [26].
In conclusion, our results showed that Rem2 did not exhibit any
observable tonic inhibitory modulation of VGCCs in cultured
hippocampal neurons and that inhibition of VGCCs during early
development did not affect synaptogenesis. Roles for Rem2 in
other aspects of neuromodulation remain unexplored, and
whether these roles are mediated through regulation of VGCC
activity will be an interesting area of future study.
Author Contributions
Conceived and designed the experiments: HGW GSP. Performed the
experiments: HGW CW. Analyzed the data: HGW GSP. Wrote the paper:
HGW GSP.
References
1. van Daalen E, Kemner C, Dietz C, Swinkels SH, Buitelaar JK, et al. (2009)
Inter-rater reliability and stability of diagnoses of autism spectrum disorder in
children identified through screening at a very young age. Eur Child Adolesc
Psychiatry 18: 663–674.
2. Peterson BZ, DeMaria CD, Adelman JP, Yue DT (1999) Calmodulin is the
Ca2+ Sensor for Ca2+ -Dependent Inactivation of L-type Calcium Channels
[published erratum appears in Neuron 1999 Apr;22(4):following 893]. Neuron
22: 549–558.
3. Zu ¨hlke RD, Pitt GS, Deisseroth K, Tsien RW, Reuter H (1999) Calmodulin
supports both inactivation and facilitation of L-type calcium channels. Nature
399: 159–162.
4. Lee A, Wong ST, Gallagher D, Li B, Storm DR, et al. (1999) Ca2+/calmodulin
binds to and modulates P/Q-type calcium channels. Nature 399: 155–159.
5. Flynn R, Zamponi GW (2010) Regulation of calcium channels by RGK
proteins. Channels 4: 434–439.
6. Beguin P, Nagashima K, Gonoi T, Shibasaki T, Takahashi K, et al. (2001)
Regulation of Ca2+ channel expression at the cell surface by the small G-protein
kir/Gem. Nature 411: 701–706.
7. Finlin BS, Crump SM, Satin J, Andres DA (2003) Regulation of voltage-gated
calciumchannel activitybytheRemandRadGTPases. ProcNatlAcadSciUSA
100: 14469–14474.
8. Seu L, Pitt GS (2006) Dose-dependent and Isoform-specific Modulation of Ca2+
Channels by RGK GTPases. J Gen Physiol 128: 605–613.
9. Fan M, Buraei Z, Luo HR, Levenson-Palmer R, Yang J (2010) Direct
inhibition of P/Q-type voltage-gated Ca2+ channels by Gem does not require
a direct Gem/Cavbeta interaction. Proc Natl Acad Sci U S A 107:
14887–14892.
10. Ward Y, Yap SF, Ravichandran V, Matsumura F, Ito M, et al. (2002) The GTP
binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase
pathway. J Cell Biol 157: 291–302.
11. Maguire J, Santoro T, Jensen P, Siebenlist U, Yewdell J, et al. (1994) Gem: an
induced, immediate early protein belonging to the Ras family. Science 265:
241–244.
12. Reynet C, Kahn CR (1993) Rad: a member of the Ras family overexpressed in
muscle of type II diabetic humans. Science 262: 1441–1444.
13. Opatowsky Y, Sasson Y, Shaked I, Ward Y, Chomsky-Hecht O, et al. (2006)
Structure-function studies of the G-domain from human gem, a novel small G-
protein. FEBS Lett 580: 5959–5964.
14. Chang L, Zhang J, Tseng Y-H, Xie C-Q, Ilany J, et al. (2007) Rad GTPase
Deficiency Leads to Cardiac Hypertrophy. Circulation 116: 2976–2983.
15. Wang G, Zhu X, Xie W, Han P, Li K, et al. (2010) Rad As a Novel Regulator of
Excitation-Contraction Coupling and {beta}-Adrenergic Signaling in Heart.
Circ Res 106: 317–327.
16. Finlin BS, Shao H, Kadono-Okuda K, Guo N, Andres DA (2000) Rem2, a new
member of the Rem/Rad/Gem/Kir family of Ras-related GTPases. Biochem J
347 Pt 1: 223–231.
Synaptogenesis in Neurons is Rem2-Independent
PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e2574117. Paradis S, Harrar DB, Lin Y, Koon AC, Hauser JL, et al. (2007) An RNAi-based
approach identifies molecules required for glutamatergic and GABAergic
synapse development. Neuron 53: 217–232.
18. Chen H, Puhl HL, 3rd, Niu SL, Mitchell DC, Ikeda SR (2005) Expression of
Rem2, an RGK family small GTPase, reduces N-type calcium current without
affecting channel surface density. J Neurosci 25: 9762–9772.
19. Wang HG, George MS, Kim J, Wang C, Pitt GS (2007) Ca2+/calmodulin
regulates trafficking of Ca(V)1.2 Ca2+ channels in cultured hippocampal
neurons. J Neurosci 27: 9086–9093.
20. Yada H, Murata M, Shimoda K, Yuasa S, Kawaguchi H, et al. (2007)
Dominant Negative Suppression of Rad Leads to QT Prolongation and Causes
Ventricular Arrhythmias via Modulation of L-type Ca2+ Channels in the Heart.
Circ Res 101: 69–77.
21. Bekkers JM, Stevens CF (1990) Presynaptic mechanism for long-term
potentiation in the hippocampus. Nature 346: 724–729.
22. Alvarez VA, Ridenour DA, Sabatini BL (2006) Retraction of Synapses and
Dendritic Spines Induced by Off-Target Effects of RNA Interference. J Neurosci
26: 7820–7825.
23. Ghiretti AE, Paradis S (2011) The GTPase Rem2 regulates synapse
development and dendritic morphology. Developmental Neurobiology 71:
374–389.
24. Edel MJ, Menchon C, Menendez S, Consiglio A, Raya A, et al. (2010) Rem2
GTPase maintains survival of human embryonic stem cells as well as enhancing
reprogramming by regulating p53 and cyclin D1. GENES & DEVELOPMENT
24: 561–573.
25. Basarsky TA, Parpura V, Haydon PG (1994) Hippocampal synaptogenesis in
cell culture: developmental time course of synapse formation, calcium influx, and
synaptic protein distribution. pp 6402–6411.
26. Greer PL, Greenberg ME (2008) From Synapse to Nucleus: Calcium-Dependent
Gene Transcription in the Control of Synapse Development and Function.
Neuron 59: 846–860.
Synaptogenesis in Neurons is Rem2-Independent
PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e25741